Opioid Crisis Raises Tough Privacy Issues

September 21, 2018 Mayuri Kumar

As CISOs, CIOs and privacy officers look for ways to boost the timely, secure sharing of healthcare information to improve treatment, one obstacle that potentially stands in the way is CFR-42 Part 2, a 1970s-era regulation.

That regulation, known as Confidentiality of Substance Use Disorder Patient Records, generally requires federally assisted substance use programs to have a patient's consent before releasing information to others involved in their treatment.

But in light of the current opioid addiction crisis, the regulation is seen by some as impeding timely treatment because it could lead to a physician not having timely access to a patient's complete drug addiction treatment history to support appropriate medical decisions.

David Holtzman’s comments are featured in this article.

Previous Article
IoT Security: How to Effectively Manage Endpoint Device Security
IoT Security: How to Effectively Manage Endpoint Device Security

IoT security is one of the most concerning and critical issues that we in healthcare face on a daily basis....

Next Article
The Top 5 Mistakes Made When Apps and Data Move to the Cloud
The Top 5 Mistakes Made When Apps and Data Move to the Cloud